Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Michael, del Aguila"'
Autor:
Maurizio Paciaroni, Birsen Ince, Bo Hu, Jiann-Shing Jeng, Kursad Kutluk, Liping Liu, Min Lou, Vladimir Parfenov, Ka Sing Lawrence Wong, Babak Zamani, Dara Paek, Jung Min Han, Michael del Aguila, Shalini Girotra
Publikováno v:
Cardiovascular Therapeutics, Vol 2019 (2019)
Aim. Though combination of clopidogrel added to aspirin has been compared to aspirin alone in patients with stroke or transient ischemic attack, limited data exists on the relative efficacy and safety between clopidogrel and aspirin monotherapy in pa
Externí odkaz:
https://doaj.org/article/48804921c97745e3b6e2af10badc81d1
Autor:
Bradley, Chipps, Ben, Taylor, Valentina, Bayer, Asif, Shaikh, Giselle, Mosnaim, Jennifer, Trevor, Sheri, Rogers, Michael, Del Aguila, Dara, Paek, Michael E, Wechsler
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 125(2)
Inhaled corticosteroids (ICSs) are recommended as first-line controller medications for persistent asthma. However, guidelines on the initial ICS doses, step-up and step-down algorithms, and when to switch to combination therapy vary.To understand th
Autor:
Kam Tim Chan, Michael del Aguila, Shalini Girotra, Dominick J. Angiolillo, Dirk Sibbing, Giuseppe Patti, Dara Paek, Wei-Chun Huang, Alexey N. Yakovlev, Yaling Han
Publikováno v:
Journal of Thrombosis and Thrombolysis
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome (ACS) may occur for a variety of reasons, including side effects (bleeding and non-bleeding) and costs. This study sought to assess the prevalence of de-escalation from ticagrelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee5e8847bea6c0d274bc4318677d15c8
http://hdl.handle.net/11697/134050
http://hdl.handle.net/11697/134050
Autor:
Shalini Girotra, Maurizio Paciaroni, Ka Sing Lawrence Wong, Birsen Ince, Min Lou, Jiann-Shing Jeng, Vladimir Anatolyevich Parfenov, Michael del Aguila, Jung Min Han, Kürşad Kutluk, Bo Hu, Babak Zamani, Liping Liu, Dara Paek
Publikováno v:
Cardiovascular Therapeutics, Vol 2019 (2019)
Cardiovascular Therapeutics
Cardiovascular Therapeutics
Aim. Though combination of clopidogrel added to aspirin has been compared to aspirin alone in patients with stroke or transient ischemic attack, limited data exists on the relative efficacy and safety between clopidogrel and aspirin monotherapy in pa
Autor:
Bradley E. Chipps, Jennifer Trevor, Valentina Bayer, Ben Taylor, Michael Del Aguila, Dara Paek, Sheri Rogers, Michael E. Wechsler, Asif Shaikh, Giselle Mosnaim
Publikováno v:
Annals of Allergy, Asthma & Immunology. 125:163-170.e3
Background Inhaled corticosteroids (ICSs) are recommended as first-line controller medications for persistent asthma. However, guidelines on the initial ICS doses, step-up and step-down algorithms, and when to switch to combination therapy vary. Obje
Autor:
Dajun Chai, Michael del Aguila, Amr Elhadidy, Dara Paek, Alessandro Lupi, Çetin Erol, Shuyang Zhang, Yaling Han, Shalini Girotra, Yihong Sun, Chunjian Li
Publikováno v:
Journal of the American College of Cardiology. 72:C215-C216
Publikováno v:
Journal of Clinical Oncology. 37:77-77
77 Background: In February 2018, ASCO published a guideline on how clinicians should manage immune-related adverse events (irAEs) in cancer patients treated with immune checkpoint inhibitors (ICPis). Recommendations were based on informal consensus d
Autor:
Zeba M. Khan, Mark J. Cziraky, William H. Crown, Michael del Aguila, Richard Migliori, Richard J. Willke
Publikováno v:
Value in Health. 16(6):S10-S15
Effective pursuit of the science and management of heterogeneity of treatment effect (HTE) relies on the mutual understanding of the perspectives of, and collaboration among, the various stakeholders in health care. In this article, we compare, contr
Autor:
Dara Paek, Amr Elhadidy, Michael del Aguila, Yihong Sun, Dajun Chai, Chunjian Li, Shalini Girotra, Alessandro Lupi, Çetin Erol, Shuyang Zhang, Yaling Han
Publikováno v:
Journal of the American College of Cardiology. 72:C111
An invasive management strategy with percutaneous coronary intervention (PCI) is recommended in patients with acute coronary syndrome (ACS), with or without ST-segment elevation, who are eligible for revascularization. However, there is still wide va
Autor:
Michael del Aguila, Michael A Nelson, Franklin W. Maddux, Sharashchandra Shetty, Brian M. Murray
Publikováno v:
Annals of Pharmacotherapy. 41:1761-1769
Anemia commonly complicates chronic kidney disease (CKD). Treating anemia of CKD with erythropoiesis-stimulating agents (ESAs) may attenuate cardiovascular and renal sequelae, reducing morbidity, mortality, and healthcare costs.To compare clinical ou